Cancer-testis antigens in haematological malignancies

British Journal of Haematology

Volumn 136, Issue 6, 2007, Pages 769-776

  Meklat, Farouk ^a,b   Li, Zhanfei ^a   Wang, Zhiqing ^a   Zhang, Yana ^a   Zhang, Jian ^a   Jewell, Andrew ^b   Lim, Seah H ^a,c  

^a Harrington Regional Medical Center Inc   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c TEXAS ONCOLOGY   (United States)

Author keywords

Cancer testis antigens; DNA methylation; Haematological malignancies

Indexed keywords

AZACITIDINE; CANCER TESTIS ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; SPERM PROTEIN 17; UNCLASSIFIED DRUG;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; CANCER RELAPSE; EPIGENETICS; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOGENICITY; IMMUNOTHERAPY; IN VIVO STUDY; LOW DRUG DOSE; MULTIPLE MYELOMA; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

ANTIGENS, NEOPLASM; CANCER VACCINES; DENDRITIC CELLS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOTHERAPY, ACTIVE; INTERLEUKINS; MALE; TESTIS;

EID: 33847353863     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06484.x     Document Type: Review

References (56)

1. Adams, S.P., Sahota, S.S., Mijovic, A., Czepulkowski, B., Padua, R.A., Mufti, G.J. & Guinn, B.A. (2002) Frequent expression of HAGE in presentation chronic myeloid leukaemias. Leukemia, 16, 2238-2242.
2. Baylin, S.B. & Herman, J.G. (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends in Genetics, 16, 168-174.
3. Boel, P., Wildmann, C., Sensi, M.L., Brasseur, R., Renauld, J.C., Coulie, P., Boon, T. & van der Bruggen, P. (1995) BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2, 167-175.
4. Borrello, I.M. & Sotomayor, E.M. (2002) Cancer vaccines for hematologic malignancies. Cancer Control, 9, 138-151.
5. Chiriva-Internati, M., Wang, Z., Bumm, K., Xue, Y., Hahn, A.B. & Lim, S.H. (2001). Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk. European Journal of Immunology, 31, 2277-2283.
6. Chiriva-Internati, M., Wang, Z., Salati, E., Bumm, K., Barlogie, B. & Lim, S.H. (2002a) Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma. Blood, 100, 961-965.
7. Chiriva-Internati, M., Wang, Z., Salati, E., Wroblewski, D. & Lim, S.H. (2002b) Successful generation of Sperm protein 17 (Sp17)-specific cytotoxic T lymphocytes from normal donors: implication for tumor-specific adoptive immunotherapy following allogeneic stem cell transplantation for Sp17-positive multiple myeloma. Scandinavian Journal of Immunology, 56, 429-433.
8. Chomez, P., de Backer, O., Bertrand, M., de Plaen, E., Boon, T. & Lucas, S. (2001) An overview of the MAGE gene family with the identification of all human members of the family. Cancer Research, 61, 5544-5551.
9. Coral, S., Singalotti, L., Altomonte, M., Engelsberg, A., Colizzi, F., Cattarossi, I., Maraskovsky, E., Jager, E., Seliger, B. & Maio, M. (2002) 5-aza-2′-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications. Clinical Cancer Research, 8, 2690-2695.
10. Dadabayev, A.R., Wang, Z., Zhang, Y., Zhang, J., Robinson, W.R. & Lim, S.H. (2005) Cancer immunotherapy targeting Sp17: when should the laboratory findings be translated to the clinics? American Journal of Hematology, 80, 6-11.
11. De Backer, O., Arden, K.C., Boretti, M., Vantomme, V., de Smet, C., Czekay, S., Viars, C.S., de Plaen, E., Brasseur, F., Chomez, P., van den Eynde, B., Boon, T. & van der Bruggen, P. (1999) Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Research, 59, 3157-3165.
12. De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F. & Boon, T. (1996) The activation of human gene MAGE-1 in tumour cells is correlated with genome-wide demethylation. Proceedings of the National Academy of Sciences of the United States of America, 93, 7149-7153.
13. De Smet, C., Lurquin, C., Lethe, B., Martelange, V. & Boon, T. (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Molecular and Cellular Biology, 19, 7327-7335.
14. Dhodapkar, M.V., Osman, K., Teruya-Feldstein, J., Filippa, D., Hedvat, C.V., Iversen, K., Kolb, D., Geller, M.D., Hassoun, H., Kewalramani, T., Comenzo, R.L., Coplan, K., Chen, Y.T. & Jungbluth, A.A. (2003) Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7 and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease. Cancer Immunity, 3, 9-14.
15. Filippini, A., Riccioli, A., Padula, F., Lauretti, P., D'Alessio, A., de Cesaris, P., Gandini, L., Lenzi, A. & Ziparo, E. (2001) Control and impairment of immune privilege in the testis and in semen. Human Reproduction, 7, 444-449.
16. Fiszer, D. & Kurpisz, M. (1998) Major histocompatibility complex expression on human, male germ cells: a review. American Journal of Reproductive Immunology, 40, 172-176.
17. Fuks, F., Hurd, P.J., Wolf, D., Nan, X., Bird, A.P. & Kouzarides, T. (2003) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. Journal of Biological Chemistry, 278, 4035-4040.
18. Goelz, S.E., Vogelstein, B., Hamilton, S.R. & Feinberg, A.P. (1985) Hypomethylation of DNA from benign and malignant human colon neoplasms. Science, 228, 187-190.
19. Grizzi, F., Chiriva-Internati, M., Franceschini, B., Hermonat, P.L., Soda, G., Lim, S.H. & Dioguardi, N. (2003) Immunolocalization of sperm protein 17 in human testis and ejaculated spermatozoa. Journal of Histochemistry and Cytochemistry, 51, 1245-1248.
20. Guinn, B., Bland, E.A., Lodi, U., Liggins, A.P., Tobal, K., Petters, S., Wells, J.W., Banham, A.H. & Mufti, G.J. (2005) Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia. Biochemical and Biophysical Research Communications, 225, 1293-1304.
21. Gure, A.O., Wei, I.J., Old, L.J. & Chen, Y.T. (2002) The SSX gene family: characterization of 9 complete genes. International Journal of Cancer, 101, 448-453.
22. Jones, P.L., Veenstra, G.J., Wade, P.A., Vermaak, D., Kass, S.U., Landberger, N., Strouboulis, J. & Wolfe, A.P. (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genetics, 19, 187-191.
23. Jungbluth, A.A., Stockert, E., Chen, Y.T., Kolb, D., Iversen, K., Coplan, K., Williamson, B., Altorki, N., Busam, K.J. & Old, L.J. (2000) Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. British Journal of Cancer, 83, 493-497.
24. Jungbluth, A.A., Ely, S., DiLiberto, M.M., Niesvizky, R., Williamson, B., Frosina, D., Chen, Y.T., Bhardwaj, N., Chen-Kiang, S., Old, L.J. & Cho, H.J. (2005) The cancer-testis antigens CT7 (MAGEC1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation. Blood, 106, 167-174.
25. Kaneda, A., Tsukamoto, T., Takamura-Enya, T., Watanabe, N., Kaminishi, M., Sugimura, T., Tatematsu, M. & Ushijima, T. (2004) Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Science, 95, 58-64.
26. Kimmins, S. & Sassone-Corsi, P. (2005) Chromatin remodeling and epigenetic features of germ cells. Nature, 434, 583-589.
27. Lewis, J.D., Meehan, R.R., Henzel, W.J., Maurer-Fogy, I., Jeppesen, P., Klein, F. & Bird, A. (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 9, 905-914.
28. Lim, S.H., Austin, S., Owen-Jones, E. & Robinson, L. (1999) Expression of testicular genes in haematological malignancies. British Journal of Cancer, 81, 1162-1164.
29. Lim, S.H., Wang, Z., Chiriva-Internati, M. & Xue, Y. (2001) Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma. Blood, 97, 1508-1510.
30. Ng, H.H. & Bird, A. (2000) Histone deacetylases: silencers for hire. Trends in Biochemical Sciences, 25, 121-126.
31. Ng, H.H., Zhang, Y., Hendrich, B., Johnson, C.A., Turner, B.M., Erdjument-Bromage, H., Tempst, P., Reinberg, D. & Bird, A. (1999) MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nature Genetics, 23, 58-61.
32. Old, L.J. & Chen, Y.T. (1998) New paths in human cancer serology. Journal of Experimental Medicine, 187, 1163-1167.
33. Paydas, S., Tanriverdi, K., Yavuz, S., Disel, U., Baslamisli, F. & Burgut, R. (2005) PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects. American Journal of Hematology, 79, 257-261.
34. Paydas, S., Tanriverdi, K., Yavuz, S. & Seydaoglu, G. (2006) PRAME mRNA levels in cases with chronic leukemia: clinical importance and review of the literature. Leukemia Research Aug 14, [Epub ahead of print]. doi:10.1016/j.leukres.2006.06.022.
35. Scanlan, M.J., Gordon, C.M., Williamson, B., Lee, S.Y., Chen, Y.T., Stockert, E., Jungbluth, A., Ritter, G., Jager, D., Jager, E., Knuth, A. & Old, L.J. (2002) Identification of cancer/testis genes by database mining and mRNA expression analysis. International Journal of Cancer, 98, 485-492.
36. Simpson, A.J., Caballero, O.L., Jungbluth, A., Chen, Y.T. & Old, L.J. (2005) Cancer/testis antigens, gametogenesis and cancer. Nature Reviews Cancer, 5, 615-625.
37. Taniura, H., Kobayashi, M. & Yoshikawa, K. (2005) Functional domains of necdin for protein-protein interaction, nuclear matrix targeting, and cell growth suppression. Journal of Cellular Biochemistry, 94, 804-815.
38. Tapparel, C., Reymond, A., Girardet, C., Guillou, L., Lyle, R., Lamon, C., Hutter, P. & Antonarakis, S.E. (2003) The TPTE gene family: cellular expression, subcellular localization and alternative splicing. Gene, 323, 189-199.
39. Tarte, K., de Vos, J., Thykjaer, T., Zhan, F., Fiol, G., Costes, V., Reme, T., Legouffe, E., Rossi, J.F., Shaughnessy, Jr, J., Orntoft, T.F. & Klein, B. (2002) Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts. Blood, 100, 1113-1122.
40. Tung, K.S. & Teuscher, C. (1995) Mechanisms of autoimmune disease in the testis and ovary. Human Reproduction, 1, 35-50.
41. Tureci, O., Sahin, U., Zwick, C., Koslowski, M., Seitz, G. & Pfreundschuh, M. (1998a) Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proceedings of the National Academy of Sciences of the United States of America, 95, 5211-5216.
42. Tureci, O., Chen, Y.T., Sahin, U., Gure, A.O., Zwick, C., Villena, C., Tsang, S., Seitz, G., Old, L.G. & Pfreundschuh, M. (1998b) Expression of SSX genes in human tumors. International Journal of Cancer, 77, 19-23.
43. Van Baren, N., Brasseur, F., Godelaine, D., Hames, G., Ferrant, A., Lehmann, F., Andre, M., Ravoet, C., Doyen, C., Spagnoli, G.C., Bakkus, M., Thielemans, K. & Boon, T. (1999) Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood, 94, 1156-1164.
44. Van Pel, A., van der Bruggen, P., Coulie, P.G., Brichard, V.G., Lethe, B., van den Eynde, B., Uyttenhove, C., Renauld, J.C. & Boon, T. (1995) Genes coding for tumour antigens recognized by cytolytic T lymphocytes. Immunological Reviews, 145, 229-250.
45. Van Rhee, F., Szmania, S.M., Zhan, F., Gupta, S.K., Pomtree, M., Lin, P., Batchu, R.B., Moreno, A., Spagnoli, G., Shaughnessy, J. & Tricot, G. (2005) NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses. Blood, 105, 3939-3944.
46. Wade, P.A. (2001) Methyl CpG binding proteins: coupling chromatin architecture to gene regulation. Oncogene, 20, 3166-3173.
47. Wang, Z., Zhang, Y., Liu, H., Salati, E., Chiriva-Internati, M. & Lim, S.H. (2003) Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies. Blood, 101, 955-960.
48. Wang, Z., Zhang, Y., Mandal, A., Zhang, J., Giles, F.J., Herr, J.C. & Lim, S.H. (2004a) The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies. Clinical Cancer Research, 19, 6544-6550.
49. Wang, Z., Zhang, Y., Ramsahoye, B., Bowen, D. & Lim, S.H. (2004b) Sp17 gene expression in myeloma cells is regulated by promoter methylation. British Journal of Cancer, 91, 1597-1603.
50. Wang, Z., Zhang, J., Zhang, Y. & Lim, S.H. (2006a) SPAN-Xb expression in myeloma cells is dependent on promoter hypomethylation and can be upregulated pharmacologically. International Journal of Cancer, 118, 1436-1444.
51. Wang, Z., Zhang, J., Zhang, Y., Srivenugopal, K.S. & Lim, S.H. (2006b) SPAN-XB core promoter sequence is regulated in myeloma cells by specific CpG dinucleotides associated with the MeCP2 protein. International Journal of Cancer, 119, 2878-2884.
52. Weber, J., Salgaller, M., Samid, D., Johnson, B., Herlyn, M., Lassam, N., Treisman, J. & Rosenberg, S.A. (1994) Expression of the MAGE-1 tumour antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine. Cancer Research, 54, 1766-1771.
53. Westbrook, V.A, Schoppee, P.D., Diekman, A.B., Klotz, K.L., Allietta, M., Hogan, K.T., Slingluff, C.L., Patterson, J.W., Frierson, H.F., Irvin, W.P., Flickinger, C.J., Coppola, M.A. & Herr, J.C. (2004) Genomic organization, incidence, and localization of the SPAN-X family of cancer-testis antigens in melanoma tumors and cell lines. Clinical Cancer Research, 10, 101-112.
54. Xu, H.P., Yuan, L., Shan, J. & Feng, H. (2004) Localization and expression of TSP50 protein in human and rodent testes. Urology, 64, 826-832.
55. Zhang, Y., Wang, Z., Liu, H., Giles, F.J. & Lim, S.H. (2003) Pattern of gene expression and immune responses to Semenogelin 1 in chronic hematologic malignancies. Journal of Immunotherapy, 26, 461-467.
56. Zhang, Y., Wang, Z., Zhang, J., Farmer, B. & Lim, S.H. (2007) Semenogelin 1 expression in myeloma cells: interaction between DNA methylation, MeCP2 protein and specific cytokines. Molecular Cancer Research (in press).